First Trust Advisors LP Gilead Sciences, Inc. Transaction History

First Trust Advisors LP

$108 Billion
Q4 2024

A detailed history of First Trust Advisors LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 2,962,221 shares of GILD stock, worth $308 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

2,962,221

Previous 2,913,779 1.66%

Holding current value

$308 Million

Previous $244 Million 12.03%

% of portfolio

0.25%

Previous 0.24%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$83.95 - $97.9 $4.07 Million - $4.74 Million	48,442 Added 1.66%	2,962,221 $274 Million
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $71.7 Million - $90.5 Million	-1,077,079 Reduced 26.99%	2,913,779 $244 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $12.1 Million - $14 Million	-192,379 Reduced 4.6%	3,990,858 $274 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $4.69 Million - $5.72 Million	65,509 Added 1.59%	4,183,237 $306 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $28 Million - $31.7 Million	-381,573 Reduced 8.48%	4,117,728 $334 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $33.6 Million - $36.6 Million	454,229 Added 11.23%	4,499,301 $337 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $139 Million - $158 Million	-1,824,781 Reduced 31.09%	4,045,072 $312 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $181 Million - $206 Million	2,339,008 Added 66.24%	5,869,853 $487 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $22.8 Million - $32.8 Million	-366,347 Reduced 9.4%	3,530,845 $303 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $34.2 Million - $39.1 Million	-574,230 Reduced 12.84%	3,897,192 $240 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $95.5 Million - $108 Million	-1,655,263 Reduced 27.02%	4,471,422 $276 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $180 Million - $226 Million	3,114,535 Added 103.4%	6,126,685 $364 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $26.6 Million - $30.2 Million	409,793 Added 15.75%	3,012,150 $219 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $15.4 Million - $16.6 Million	-226,890 Reduced 8.02%	2,602,357 $182 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $34 Million - $37.2 Million	536,113 Added 23.38%	2,829,247 $195 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $1.86 Million - $2.12 Million	31,017 Added 1.37%	2,293,134 $148 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $76.8 Million - $87.5 Million	-1,355,696 Reduced 37.47%	2,262,117 $132 Million
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $23.6 Million - $29.7 Million	380,737 Added 11.76%	3,617,813 $229 Million
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $123 Million - $143 Million	1,701,510 Added 110.81%	3,237,076 $249 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $3.05 Million - $3.9 Million	-48,629 Reduced 3.07%	1,535,566 $115 Million
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $54.2 Million - $59.6 Million	-879,585 Reduced 35.7%	1,584,195 $103 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $22.6 Million - $25 Million	-361,927 Reduced 12.81%	2,463,780 $156 Million
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $76.5 Million - $85.8 Million	1,236,379 Added 77.79%	2,825,707 $191 Million
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $16 Million - $17.9 Million	255,863 Added 19.19%	1,589,328 $103 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $3.75 Million - $4.89 Million	-61,874 Reduced 4.43%	1,333,465 $83.4 Million
Q3 2018 Oct 25, 2018	BUY	$71.28 - $78.92 $29.6 Million - $32.8 Million	415,500 Added 42.4%	1,395,339 $108 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $19.6 Million - $22.8 Million	-301,694 Reduced 23.54%	979,839 $69.4 Million
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $12.5 Million - $15.2 Million	171,189 Added 15.42%	1,281,533 $96.6 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $5.64 Million - $6.62 Million	-79,304 Reduced 6.67%	1,110,344 $79.5 Million
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $85.8 Million - $102 Million	1,189,648	1,189,648 $96.4 Million

Others Institutions Holding GILD

# of Institutions

2,072

Shares Held

1.02B

Call Options Held

9.63M

Put Options Held

10.2M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $130B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Gilead Sciences, Inc. Transaction History